The global market for Diagnostic Biomarkers was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Diagnostic Biomarkers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostic Biomarkers.

The Diagnostic Biomarkers market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Diagnostic Biomarkers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Diagnostic Biomarkers companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Diagnostic Biomarkers Market Report

Report Metric	Details
Report Name	Diagnostic Biomarkers Market
CAGR	5%
Segment by Type	Safety Biomarkers Efficacy Biomarkers Validation Biomarkers
Segment by Application	Hospitals Cancer Research Institutes Diagnostic Labs
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Qiagen N.V., Perkinelmer, Inc., Merck Millipore, Bio-Rad Laboratories, Inc., Enzo Biochem, Inc., EKF Diagnostics Holdings, Inc., Meso Scale Diagnostics, LLC., Biosims Technologies Sas, Cisbio Bioassays, Signosis, Inc, Banyan Biomarkers, Inc, Biomedical Corp
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diagnostic Biomarkers company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Diagnostic Biomarkers Market report?

Ans: The main players in the Diagnostic Biomarkers Market are Qiagen N.V., Perkinelmer, Inc., Merck Millipore, Bio-Rad Laboratories, Inc., Enzo Biochem, Inc., EKF Diagnostics Holdings, Inc., Meso Scale Diagnostics, LLC., Biosims Technologies Sas, Cisbio Bioassays, Signosis, Inc, Banyan Biomarkers, Inc, Biomedical Corp

What are the Application segmentation covered in the Diagnostic Biomarkers Market report?

Ans: The Applications covered in the Diagnostic Biomarkers Market report are Hospitals, Cancer Research Institutes, Diagnostic Labs

What are the Type segmentation covered in the Diagnostic Biomarkers Market report?

Ans: The Types covered in the Diagnostic Biomarkers Market report are Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Diagnostic Biomarkers Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Safety Biomarkers

1.2.3 Efficacy Biomarkers

1.2.4 Validation Biomarkers

1.3 Market by Application

1.3.1 Global Diagnostic Biomarkers Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Cancer Research Institutes

1.3.4 Diagnostic Labs

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Diagnostic Biomarkers Market Perspective (2020-2031)

2.2 Global Diagnostic Biomarkers Growth Trends by Region

2.2.1 Global Diagnostic Biomarkers Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Diagnostic Biomarkers Historic Market Size by Region (2020-2025)

2.2.3 Diagnostic Biomarkers Forecasted Market Size by Region (2026-2031)

2.3 Diagnostic Biomarkers Market Dynamics

2.3.1 Diagnostic Biomarkers Industry Trends

2.3.2 Diagnostic Biomarkers Market Drivers

2.3.3 Diagnostic Biomarkers Market Challenges

2.3.4 Diagnostic Biomarkers Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Diagnostic Biomarkers Players by Revenue

3.1.1 Global Top Diagnostic Biomarkers Players by Revenue (2020-2025)

3.1.2 Global Diagnostic Biomarkers Revenue Market Share by Players (2020-2025)

3.2 Global Diagnostic Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Diagnostic Biomarkers Revenue

3.4 Global Diagnostic Biomarkers Market Concentration Ratio

3.4.1 Global Diagnostic Biomarkers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Diagnostic Biomarkers Revenue in 2024

3.5 Global Key Players of Diagnostic Biomarkers Head office and Area Served

3.6 Global Key Players of Diagnostic Biomarkers, Product and Application

3.7 Global Key Players of Diagnostic Biomarkers, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Diagnostic Biomarkers Breakdown Data by Type

4.1 Global Diagnostic Biomarkers Historic Market Size by Type (2020-2025)

4.2 Global Diagnostic Biomarkers Forecasted Market Size by Type (2026-2031)

5 Diagnostic Biomarkers Breakdown Data by Application

5.1 Global Diagnostic Biomarkers Historic Market Size by Application (2020-2025)

5.2 Global Diagnostic Biomarkers Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Diagnostic Biomarkers Market Size (2020-2031)

6.2 North America Diagnostic Biomarkers Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Diagnostic Biomarkers Market Size by Country (2020-2025)

6.4 North America Diagnostic Biomarkers Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Diagnostic Biomarkers Market Size (2020-2031)

7.2 Europe Diagnostic Biomarkers Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Diagnostic Biomarkers Market Size by Country (2020-2025)

7.4 Europe Diagnostic Biomarkers Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Diagnostic Biomarkers Market Size (2020-2031)

8.2 Asia-Pacific Diagnostic Biomarkers Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Diagnostic Biomarkers Market Size by Region (2020-2025)

8.4 Asia-Pacific Diagnostic Biomarkers Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Diagnostic Biomarkers Market Size (2020-2031)

9.2 Latin America Diagnostic Biomarkers Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Diagnostic Biomarkers Market Size by Country (2020-2025)

9.4 Latin America Diagnostic Biomarkers Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Diagnostic Biomarkers Market Size (2020-2031)

10.2 Middle East & Africa Diagnostic Biomarkers Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Diagnostic Biomarkers Market Size by Country (2020-2025)

10.4 Middle East & Africa Diagnostic Biomarkers Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Qiagen N.V.

11.1.1 Qiagen N.V. Company Details

11.1.2 Qiagen N.V. Business Overview

11.1.3 Qiagen N.V. Diagnostic Biomarkers Introduction

11.1.4 Qiagen N.V. Revenue in Diagnostic Biomarkers Business (2020-2025)

11.1.5 Qiagen N.V. Recent Development

11.2 Perkinelmer, Inc.

11.2.1 Perkinelmer, Inc. Company Details

11.2.2 Perkinelmer, Inc. Business Overview

11.2.3 Perkinelmer, Inc. Diagnostic Biomarkers Introduction

11.2.4 Perkinelmer, Inc. Revenue in Diagnostic Biomarkers Business (2020-2025)

11.2.5 Perkinelmer, Inc. Recent Development

11.3 Merck Millipore

11.3.1 Merck Millipore Company Details

11.3.2 Merck Millipore Business Overview

11.3.3 Merck Millipore Diagnostic Biomarkers Introduction

11.3.4 Merck Millipore Revenue in Diagnostic Biomarkers Business (2020-2025)

11.3.5 Merck Millipore Recent Development

11.4 Bio-Rad Laboratories, Inc.

11.4.1 Bio-Rad Laboratories, Inc. Company Details

11.4.2 Bio-Rad Laboratories, Inc. Business Overview

11.4.3 Bio-Rad Laboratories, Inc. Diagnostic Biomarkers Introduction

11.4.4 Bio-Rad Laboratories, Inc. Revenue in Diagnostic Biomarkers Business (2020-2025)

11.4.5 Bio-Rad Laboratories, Inc. Recent Development

11.5 Enzo Biochem, Inc.

11.5.1 Enzo Biochem, Inc. Company Details

11.5.2 Enzo Biochem, Inc. Business Overview

11.5.3 Enzo Biochem, Inc. Diagnostic Biomarkers Introduction

11.5.4 Enzo Biochem, Inc. Revenue in Diagnostic Biomarkers Business (2020-2025)

11.5.5 Enzo Biochem, Inc. Recent Development

11.6 EKF Diagnostics Holdings, Inc.

11.6.1 EKF Diagnostics Holdings, Inc. Company Details

11.6.2 EKF Diagnostics Holdings, Inc. Business Overview

11.6.3 EKF Diagnostics Holdings, Inc. Diagnostic Biomarkers Introduction

11.6.4 EKF Diagnostics Holdings, Inc. Revenue in Diagnostic Biomarkers Business (2020-2025)

11.6.5 EKF Diagnostics Holdings, Inc. Recent Development

11.7 Meso Scale Diagnostics, LLC.

11.7.1 Meso Scale Diagnostics, LLC. Company Details

11.7.2 Meso Scale Diagnostics, LLC. Business Overview

11.7.3 Meso Scale Diagnostics, LLC. Diagnostic Biomarkers Introduction

11.7.4 Meso Scale Diagnostics, LLC. Revenue in Diagnostic Biomarkers Business (2020-2025)

11.7.5 Meso Scale Diagnostics, LLC. Recent Development

11.8 Biosims Technologies Sas

11.8.1 Biosims Technologies Sas Company Details

11.8.2 Biosims Technologies Sas Business Overview

11.8.3 Biosims Technologies Sas Diagnostic Biomarkers Introduction

11.8.4 Biosims Technologies Sas Revenue in Diagnostic Biomarkers Business (2020-2025)

11.8.5 Biosims Technologies Sas Recent Development

11.9 Cisbio Bioassays

11.9.1 Cisbio Bioassays Company Details

11.9.2 Cisbio Bioassays Business Overview

11.9.3 Cisbio Bioassays Diagnostic Biomarkers Introduction

11.9.4 Cisbio Bioassays Revenue in Diagnostic Biomarkers Business (2020-2025)

11.9.5 Cisbio Bioassays Recent Development

11.10 Signosis, Inc

11.10.1 Signosis, Inc Company Details

11.10.2 Signosis, Inc Business Overview

11.10.3 Signosis, Inc Diagnostic Biomarkers Introduction

11.10.4 Signosis, Inc Revenue in Diagnostic Biomarkers Business (2020-2025)

11.10.5 Signosis, Inc Recent Development

11.11 Banyan Biomarkers, Inc

11.11.1 Banyan Biomarkers, Inc Company Details

11.11.2 Banyan Biomarkers, Inc Business Overview

11.11.3 Banyan Biomarkers, Inc Diagnostic Biomarkers Introduction

11.11.4 Banyan Biomarkers, Inc Revenue in Diagnostic Biomarkers Business (2020-2025)

11.11.5 Banyan Biomarkers, Inc Recent Development

11.12 Biomedical Corp

11.12.1 Biomedical Corp Company Details

11.12.2 Biomedical Corp Business Overview

11.12.3 Biomedical Corp Diagnostic Biomarkers Introduction

11.12.4 Biomedical Corp Revenue in Diagnostic Biomarkers Business (2020-2025)

11.12.5 Biomedical Corp Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

QIAGEN N V

PerkinElmer Inc

Bio-Rad Laboratories Inc

Enzo Biochem, Inc.

EKF Diagnostics Holdings, Inc.

Meso Scale Diagnostics, LLC.

Biosims Technologies Sas

Cisbio Bioassays

Signosis

Banyan Biomarkers, Inc

Biomedical Corp

Merck

Merck Millipore

List of Tables

Table 1. Global Diagnostic Biomarkers Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Safety Biomarkers

Table 3. Key Players of Efficacy Biomarkers

Table 4. Key Players of Validation Biomarkers

Table 5. Global Diagnostic Biomarkers Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Diagnostic Biomarkers Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Diagnostic Biomarkers Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Diagnostic Biomarkers Market Share by Region (2020-2025)

Table 9. Global Diagnostic Biomarkers Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Diagnostic Biomarkers Market Share by Region (2026-2031)

Table 11. Diagnostic Biomarkers Market Trends

Table 12. Diagnostic Biomarkers Market Drivers

Table 13. Diagnostic Biomarkers Market Challenges

Table 14. Diagnostic Biomarkers Market Restraints

Table 15. Global Diagnostic Biomarkers Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Diagnostic Biomarkers Market Share by Players (2020-2025)

Table 17. Global Top Diagnostic Biomarkers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Biomarkers as of 2024)

Table 18. Ranking of Global Top Diagnostic Biomarkers Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Diagnostic Biomarkers Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Diagnostic Biomarkers, Headquarters and Area Served

Table 21. Global Key Players of Diagnostic Biomarkers, Product and Application

Table 22. Global Key Players of Diagnostic Biomarkers, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Diagnostic Biomarkers Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Diagnostic Biomarkers Revenue Market Share by Type (2020-2025)

Table 26. Global Diagnostic Biomarkers Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Diagnostic Biomarkers Revenue Market Share by Type (2026-2031)

Table 28. Global Diagnostic Biomarkers Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Diagnostic Biomarkers Revenue Market Share by Application (2020-2025)

Table 30. Global Diagnostic Biomarkers Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Diagnostic Biomarkers Revenue Market Share by Application (2026-2031)

Table 32. North America Diagnostic Biomarkers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Diagnostic Biomarkers Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Diagnostic Biomarkers Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Diagnostic Biomarkers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Diagnostic Biomarkers Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Diagnostic Biomarkers Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Diagnostic Biomarkers Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Diagnostic Biomarkers Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Diagnostic Biomarkers Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Diagnostic Biomarkers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Diagnostic Biomarkers Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Diagnostic Biomarkers Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Diagnostic Biomarkers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Diagnostic Biomarkers Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Diagnostic Biomarkers Market Size by Country (2026-2031) & (US$ Million)

Table 47. Qiagen N.V. Company Details

Table 48. Qiagen N.V. Business Overview

Table 49. Qiagen N.V. Diagnostic Biomarkers Product

Table 50. Qiagen N.V. Revenue in Diagnostic Biomarkers Business (2020-2025) & (US$ Million)

Table 51. Qiagen N.V. Recent Development

Table 52. Perkinelmer, Inc. Company Details

Table 53. Perkinelmer, Inc. Business Overview

Table 54. Perkinelmer, Inc. Diagnostic Biomarkers Product

Table 55. Perkinelmer, Inc. Revenue in Diagnostic Biomarkers Business (2020-2025) & (US$ Million)

Table 56. Perkinelmer, Inc. Recent Development

Table 57. Merck Millipore Company Details

Table 58. Merck Millipore Business Overview

Table 59. Merck Millipore Diagnostic Biomarkers Product

Table 60. Merck Millipore Revenue in Diagnostic Biomarkers Business (2020-2025) & (US$ Million)

Table 61. Merck Millipore Recent Development

Table 62. Bio-Rad Laboratories, Inc. Company Details

Table 63. Bio-Rad Laboratories, Inc. Business Overview

Table 64. Bio-Rad Laboratories, Inc. Diagnostic Biomarkers Product

Table 65. Bio-Rad Laboratories, Inc. Revenue in Diagnostic Biomarkers Business (2020-2025) & (US$ Million)

Table 66. Bio-Rad Laboratories, Inc. Recent Development

Table 67. Enzo Biochem, Inc. Company Details

Table 68. Enzo Biochem, Inc. Business Overview

Table 69. Enzo Biochem, Inc. Diagnostic Biomarkers Product

Table 70. Enzo Biochem, Inc. Revenue in Diagnostic Biomarkers Business (2020-2025) & (US$ Million)

Table 71. Enzo Biochem, Inc. Recent Development

Table 72. EKF Diagnostics Holdings, Inc. Company Details

Table 73. EKF Diagnostics Holdings, Inc. Business Overview

Table 74. EKF Diagnostics Holdings, Inc. Diagnostic Biomarkers Product

Table 75. EKF Diagnostics Holdings, Inc. Revenue in Diagnostic Biomarkers Business (2020-2025) & (US$ Million)

Table 76. EKF Diagnostics Holdings, Inc. Recent Development

Table 77. Meso Scale Diagnostics, LLC. Company Details

Table 78. Meso Scale Diagnostics, LLC. Business Overview

Table 79. Meso Scale Diagnostics, LLC. Diagnostic Biomarkers Product

Table 80. Meso Scale Diagnostics, LLC. Revenue in Diagnostic Biomarkers Business (2020-2025) & (US$ Million)

Table 81. Meso Scale Diagnostics, LLC. Recent Development

Table 82. Biosims Technologies Sas Company Details

Table 83. Biosims Technologies Sas Business Overview

Table 84. Biosims Technologies Sas Diagnostic Biomarkers Product

Table 85. Biosims Technologies Sas Revenue in Diagnostic Biomarkers Business (2020-2025) & (US$ Million)

Table 86. Biosims Technologies Sas Recent Development

Table 87. Cisbio Bioassays Company Details

Table 88. Cisbio Bioassays Business Overview

Table 89. Cisbio Bioassays Diagnostic Biomarkers Product

Table 90. Cisbio Bioassays Revenue in Diagnostic Biomarkers Business (2020-2025) & (US$ Million)

Table 91. Cisbio Bioassays Recent Development

Table 92. Signosis, Inc Company Details

Table 93. Signosis, Inc Business Overview

Table 94. Signosis, Inc Diagnostic Biomarkers Product

Table 95. Signosis, Inc Revenue in Diagnostic Biomarkers Business (2020-2025) & (US$ Million)

Table 96. Signosis, Inc Recent Development

Table 97. Banyan Biomarkers, Inc Company Details

Table 98. Banyan Biomarkers, Inc Business Overview

Table 99. Banyan Biomarkers, Inc Diagnostic Biomarkers Product

Table 100. Banyan Biomarkers, Inc Revenue in Diagnostic Biomarkers Business (2020-2025) & (US$ Million)

Table 101. Banyan Biomarkers, Inc Recent Development

Table 102. Biomedical Corp Company Details

Table 103. Biomedical Corp Business Overview

Table 104. Biomedical Corp Diagnostic Biomarkers Product

Table 105. Biomedical Corp Revenue in Diagnostic Biomarkers Business (2020-2025) & (US$ Million)

Table 106. Biomedical Corp Recent Development

Table 107. Research Programs/Design for This Report

Table 108. Key Data Information from Secondary Sources

Table 109. Key Data Information from Primary Sources

Table 110. Authors List of This Report

List of Figures

Figure 1. Diagnostic Biomarkers Picture

Figure 2. Global Diagnostic Biomarkers Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Diagnostic Biomarkers Market Share by Type: 2024 VS 2031

Figure 4. Safety Biomarkers Features

Figure 5. Efficacy Biomarkers Features

Figure 6. Validation Biomarkers Features

Figure 7. Global Diagnostic Biomarkers Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Diagnostic Biomarkers Market Share by Application: 2024 VS 2031

Figure 9. Hospitals Case Studies

Figure 10. Cancer Research Institutes Case Studies

Figure 11. Diagnostic Labs Case Studies

Figure 12. Diagnostic Biomarkers Report Years Considered

Figure 13. Global Diagnostic Biomarkers Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Diagnostic Biomarkers Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Diagnostic Biomarkers Market Share by Region: 2024 VS 2031

Figure 16. Global Diagnostic Biomarkers Market Share by Players in 2024

Figure 17. Global Top Diagnostic Biomarkers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Biomarkers as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Diagnostic Biomarkers Revenue in 2024

Figure 19. North America Diagnostic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Diagnostic Biomarkers Market Share by Country (2020-2031)

Figure 21. United States Diagnostic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Diagnostic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Diagnostic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Diagnostic Biomarkers Market Share by Country (2020-2031)

Figure 25. Germany Diagnostic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Diagnostic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Diagnostic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Diagnostic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Diagnostic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Diagnostic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Diagnostic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Diagnostic Biomarkers Market Share by Region (2020-2031)

Figure 33. China Diagnostic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Diagnostic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Diagnostic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Diagnostic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Diagnostic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Diagnostic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Diagnostic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Diagnostic Biomarkers Market Share by Country (2020-2031)

Figure 41. Mexico Diagnostic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Diagnostic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Diagnostic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Diagnostic Biomarkers Market Share by Country (2020-2031)

Figure 45. Turkey Diagnostic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Diagnostic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Diagnostic Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Qiagen N.V. Revenue Growth Rate in Diagnostic Biomarkers Business (2020-2025)

Figure 49. Perkinelmer, Inc. Revenue Growth Rate in Diagnostic Biomarkers Business (2020-2025)

Figure 50. Merck Millipore Revenue Growth Rate in Diagnostic Biomarkers Business (2020-2025)

Figure 51. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Diagnostic Biomarkers Business (2020-2025)

Figure 52. Enzo Biochem, Inc. Revenue Growth Rate in Diagnostic Biomarkers Business (2020-2025)

Figure 53. EKF Diagnostics Holdings, Inc. Revenue Growth Rate in Diagnostic Biomarkers Business (2020-2025)

Figure 54. Meso Scale Diagnostics, LLC. Revenue Growth Rate in Diagnostic Biomarkers Business (2020-2025)

Figure 55. Biosims Technologies Sas Revenue Growth Rate in Diagnostic Biomarkers Business (2020-2025)

Figure 56. Cisbio Bioassays Revenue Growth Rate in Diagnostic Biomarkers Business (2020-2025)

Figure 57. Signosis, Inc Revenue Growth Rate in Diagnostic Biomarkers Business (2020-2025)

Figure 58. Banyan Biomarkers, Inc Revenue Growth Rate in Diagnostic Biomarkers Business (2020-2025)

Figure 59. Biomedical Corp Revenue Growth Rate in Diagnostic Biomarkers Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-6Q20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-35Z19949

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26E19785

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions